Lekan Daramola

Consultant at LD BioConsulting Limited

Speaker

Lekan Daramola is an independent consultant who specialises in supporting biotech, start-ups, big pharma, non-profit companies etc during the critical early drug development activities, enabling successful preclinical and clinical decisions as they develop new drugs for patients.Lekan has extensive experience working in the biopharmaceutical industry, with over 26 years contribution to different areas of biologics drug development. Lekan’s experience spans lead drug molecule selection to regulatory submission of biologics formats such as monoclonal antibodies and in the development of novel drug modalities like nucleic acid drugs/vaccine (RNA, DNA) as well as AAV (viral vector) production platform development. His expertise includes molecular biology, mammalian recombinant protein expression technologies, cell line development and early CMC support.Prior to his current role, Lekan was a Senior Director at AstraZeneca, managing mammalian expression activities, the development of nucleic acid and AAV production capabilities to deliver preclinical and clinical drug development goals. He has a wide experience of leading and managing diverse teams and delivery of drug development projects, in addition to academia and industrial collaborations. Lekan has also successfully led the development of proprietary expression platforms and established new technology platforms.